Stereotactic body radiation therapy for bone oligometastases - Archive ouverte HAL
Article Dans Une Revue Cancer/Radiothérapie Année : 2023

Stereotactic body radiation therapy for bone oligometastases

Résumé

Stereotactic body radiation therapy is effective for the local management of oligometastases (at most five metastases) with a benefit in survival and local control. Most studies on the management of oligometastases focus on all oligometastatic sites in primary cancer and very few focus on a single oligometastatic site. In particular, there are few data on bone oligometastases, which represent one of the preferred sites for secondary cancer locations. This article focuses on the benefit of stereotactic radiotherapy for bone oligometastases of all cancers by histological types, and reviews the results of major studies in this field.
Fichier non déposé

Dates et versions

hal-04783177 , version 1 (14-11-2024)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

C. Naessens, J. Chamois, S. Supiot, J.-C. Faivre, A. Arnaud, et al.. Stereotactic body radiation therapy for bone oligometastases. Cancer/Radiothérapie, 2023, 28 (1), pp.111-118. ⟨10.1016/j.canrad.2023.04.006⟩. ⟨hal-04783177⟩
7 Consultations
0 Téléchargements

Altmetric

Partager

More